Skip to main content
Erschienen in: BMC Surgery 1/2023

Open Access 01.12.2023 | Research

Efficacy of various surgical approaches in treating hematospermia using transurethral seminal vesiculoscopy

verfasst von: Rui-Jie Yao, Hong Xiao, Shu-Shen Chen, Zhi-Hao Feng, Yi-Lang Ding, Xi Chen, Song-Xi Tang, Hui-Liang Zhou

Erschienen in: BMC Surgery | Ausgabe 1/2023

Abstract

Purpose

To explore the efficacy of different approaches of seminal vesiculoscopy surgery and the predictive factors of good treatment outcome.

Materials and Methods

A retrospective analysis of 68 patients who underwent seminal vesiculoscopy for hematospermia in our hospital from January 2015 to January 2021. According to different surgical approaches, they were divided into three groups: natural ejaculatory ducts (method A, 45 cases), assisted transurethral resection/incision of ejaculatory ducts (method B, 14 cases), fenestration in prostatic utricle (method C, 9 cases). We analyzed the recurrence rate of the three surgical approaches and the predictive factors of treatment efficacy.

Results

The total recurrence rate after the seminal vesiculoscopy for hematospermia in this group was 32.35%. The postoperative recurrence rates of the three methods were 24.44% for method A, 50.00% for method B and 44.44% for method C, and there was no significant difference among the three methods (P > 0.05). The data of five predictors of 45 cases in method A group were included in the Univariate Logistic analysis, the results suggest that whether complicated with seminal tract stones/cysts was an effective predictor (OR 0.250, P = 0.022), which was still an effective predictor in the Multivariate Logistic analysis model (OR 0.244, P = 0.010).

Conclusions

The Transurethral seminal vesiculoscopy technique demonstrates a low postoperative recurrence rate in treating hematospermia. Among the various approaches, the intraoperative use of natural orifices through the ejaculatory duct exhibits the lowest recurrence rate. Additionally, seminal tract stones/cysts effectively predict favorable postoperative outcomes.
Hinweise
Rui-Jie Yao and Hong Xiao contributed equally to this study.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
TURED/TUIED
Assisted transurethral resection/incision of ejaculatory ducts
PU
Prostatic utricle
MRI
Magnetic Resonance Imaging
CT
Computerized Tomography
TRUS
Transrectal ultrasound screening

Introduction

Hematospermia is a distressing symptom with various potential causes, including genitourinary system infections, vascular malformations, stones, inflammations, tumors, and systemic diseases associated with bleeding risks. While most cases are self-limiting, patients experiencing frequent or persistent hematospermia necessitate a thorough evaluation of urologist intervention [1].
Hematospermia treatment involves conservative and surgical approaches. Conservative treatment includes antibiotics against pathogenic microbial infections and medications like Finasteride for hematospermia caused by Benign Prostatic Hyperplasia. After excluding other organic diseases, Finasteride also can benefit patients with idiopathic and refractory hematospermia [2]. However, long-term medication and high recurrence rates are significant concerns with refractory hematospermia [3]. Surgical treatment includes open surgery, laparoscopic techniques, and transurethral seminal vesiculoscopy. Accessing the seminal vesicle can be challenging due to its deep location in the pelvis. Laparoscopy and open surgery require extensive dissection, are time-consuming, and carry risks, including severe bleeding and damage to peritoneal organs like the rectum [4]. In 1998, Yang et al. successfully performed an endoscopic examination of the seminal vesicles for the first time [3], opening new avenues for seminal tract and vesicle examination and treatment. Numerous clinical studies have shown the safety and efficacy of transurethral seminal vesiculoscopy [3]. According to the local patency of the ejaculatory duct orifice, the surgical approaches include the following: (A) the natural ejaculatory duct; (B) transurethral resection/incision of ejaculatory duct (TURED/TUIED) combined with seminal vesiculoscopy; (C) the fenestration in prostatic utricle (PU) combined with seminal vesiculoscopy; and (D) seminal vesiculoscopy through the pathological opening in PU [5]. Currently, there is limited comparative data available on the efficacy of different surgical approaches for treating hematospermia. Perhaps surgical procedures that can be performed through natural orifices without incisions preserve the original anatomical structure to a greater extent, and minimize local injury.Therefore, this study aimed to explore the efficacy of different surgical approaches for treating hematospermia using seminal vesiculoscopy.

Materials and methods

Clinical data

Between January 2015 and January 2021, data were collected from patients with hematospermiawho underwent seminal vesiculoscopy at the First Affiliated Hospital of Fujian Medical University. The Ethics committee of the same hospital approved the study. All patients failed or responded poorly to at least one conservative therapy for three months. Patients underwent routine Magnetic Resonance Imaging (MRI) scans of the seminal vesicle, including enhanced examination before surgery. Subsequently, all patients underwent seminal vesiculoscopy surgery.
Inclusion criteria for surgery were as follows: (1) Persistent, typical hematospermia; (2) Normal urine routine and prostatic fluid examination; and (3) Persistent or recurrent hematospermia despite 3–6 months of systemic antibiotics or local physical therapy.
Exclusion criteria were: (1) Patients with congenital abnormalities or genitourinary tract tumors confirmed by preoperative MRI and transrectal ultrasonography; and (2) Patients with systemic hemorrhagic disease.
The study included 68 patients aged 22–65 years, with an average age of 40.49 years. The disease duration ranged from 3–240 months, with a median of 14.5 months. Among the cases, 39 (57.35%) were unilateral, and 29 (42.65%) were bilateral. MRI scan revealed fresh bleeding in seven (10.29%) cases. Additionally, 43 (63.24%) cases had complicated with seminal tract stones/cysts. Method A was used in 45 (66.18%) cases, method B in 14 (20.59%) cases, and method C in nine (13.23%) cases (Table 1).
Table 1
Demographic data of enrolled patients
Age, year (mean ± SD)
40.49 ± 11.40
Duration, month, median (interquartile range)
14.50 (9.25, 36.0)
Side of the lesion, n (percentage)
 Unilateral
39 (57.35%)
 Bilateral
29 (42.65%)
Fresh bleeding revealed by MRI, n (percentage)
 Yes
7 (10.29%)
 No
61 (89.71%)
Seminal tract stones/cysts, n (percentage)
 
 Yes
43 (63.24%)
 No
25 (36.76%)
Surgical approach, n (percentage)
 
 A
45 (66.18%)
 B
14 (20.59%)
 C
9 (13.23%)
A: the natural ejaculatory duct approach, B: transurethral resection/incision of ejaculatory duct (TURED/TUIED) combined with seminal vesiculoscopy, C: the fenestration in prostatic utricle (PU) combined with seminal vesiculoscopy

Observation indicators

The variables analyzed in this study included age, disease duration, unilateral/bilateral lesions, seminal vesicle MRI showing fresh or non-fresh bleeding, whether complicated with seminal tract stones/cysts, and the surgical approach. Recurrence was assessed during a 1-year follow-up, with criteria for recurrence defined as first ejaculation in the first week of surgery, regular weekly ejaculations, and at least one ejaculation; the presence of visible blood in the semen one month after surgery was normal. It is a recurrence when visible blood remains in the semen three months after the operation. The predictive factors associated with postoperative outcomes were included in the statistical analysis.

Surgical methods

Following anesthesia, the patient was placed in lithotomy position. The outer urethra was identified as the reference point, followed by routine disinfection and drape the area. A 12F catheter was inserted for drainage, and a Wolf 4.5/6.5F rigid ureteroscope was used as the surgical endoscope, connected to a TV imaging system. The endoscope was carefully introduced into the bladder through the urethra, using normal saline as the perfusion solution. The urethra and bladder were meticulously examined for stones, diverticulum, and tumors.
Subsequently, the selection of the surgical approach was primarily based on exploring the ejaculatory duct orifice. Following are the detailed descriptions of the surgical procedures for each approach:
  • Method A: Retract the endoscope body to the verumontanum to assess the normal appearance and shape of the verumontanum. Subsequently, the seminal vesiculoscope was inserted into the PU to explore and exit the PU. At the 5 o'clock position, the left seminal vesicle cavity was assessed to examine for bleeding, stones, cysts, or old blood clots. Normal saline was used for repeated rinsing. If stones were present, seminal vesicle lithotripsy was performed using a holmium laser to crush the stones into powder, followed by thorough rinsing and clearance. In cases of a seminal vesicle cyst or ejaculatory duct cyst, a relevant cystectomy was performed. The endoscope was then withdrawn to the left ejaculatory duct orifice, repositioning the PU, and subsequently, the right seminal vesicle was accessed at the 7 o'clock position in the PU. The exploration and treatment of the seminal vesicle cavity followed the same procedure (Fig. 1).
  • Method B: Resection/incision through the ejaculatory duct of the urethra if the ejaculatory duct orifice or PU orifice were obstructed. Subsequently, the seminal vesicle cavity was accessed through the ejaculatory duct using the same approach; The exploration and treatment of the seminal vesicle cavity followed the same procedure (Fig. 2).
  • Method C: If locating the ejaculatory duct orifice was challenging or when the orifice was obstructed or not amenable to recanalization at the PU, the seminal vesicle cavity was penetrated through the weak mucosa side channel, guided by the Zebra Urological Guidewire (Fig. 3).
During the operation, a routine bacterial culture of the seminal vesicle flushing fluid is performed for all patients. No active bleeding in the surgical cavity was confirmed. Following the procedure, a 16F three-chamber silicone urinary catheter was indwelled, and 15 ml of water was injected to complete the operation.

Statistical analysis

The statistical analysis of the data was conducted using SPSS 26.0 software. Normally distributed data were expressed as mean ± standard deviation (x̅ ± S), whilenon-normally distributed variables were expressed as median (25% and 75% interquartile range). Categorical variables were presented with number (percentage).The postoperative recurrence rates for different methods were assessed using Fisher's test. The potential predictive factors were selected for Univariate Logistic analysis, and the factors with significant differences were further analyzed for Multivariate Logistic regression analysis to identify the predictive factors with good therapeutic effect. If p remained below 0.05, the predictors were considered statistically significant. Statistical significance was determined at p < 0.05 for bilateral analysis.

Results

Surgical efficacy

All 68 patients underwent the operation without obvious complications, including bleeding, perineal pain and discomfort, ejaculation dysfunction, orchitis, epididymitis, and others. Within one year after surgery, recurrence was observed in 11 patients (24.44%) treated with method A, seven patients (50.00%) treated with method B, and four patients (44.44%) treated with method C. No significant difference was observed in the recurrence rates of different approaches (p = 0.144). (Table 2).
Table 2
Comparison of the efficacy of three surgical approaches (n = 68)
Surgical methods
recurrent
Non-recurrent
Recurrence rate (%)
P
Method A
11
34
24.44
0.144
Method B
7
7
50.00
Method C
4
5
44.44
A: the natural ejaculatory duct approach, B: transurethral resection/incision of ejaculatory duct (TURED/TUIED) combined with seminal vesiculoscopy, C: the fenestration in prostatic utricle (PU) combined with seminal vesiculoscopy
Patients were informed before the operation that in certain cases of resistant hematospermia, the underlying cause of the condition may remain unclear even after surgery. In such instances, continuing conservative treatment can be considered if surgical treatment fails.

Analysis of predictive factors of good postoperative outcome (A method)

Based on the one-year postoperative outcomes of hematospermia, five factors were analyzed, including age, disease duration, presence of stones/cysts in the seminal tract during surgery, unilateral/bilateral lesions, and the presence of fresh or non-fresh bleeding on seminal vesicle MRIs. A Multivariate Logistic analysis was performed specifically for method A due to a limited number of cases for the B and C methods. The analysis revealed that intraoperative complicated with seminal tract stones/cysts were statistically significant (p = 0.022 OR 0.250). Subsequently, multiple logistic analysis was conducted, and the significance remained (p = 0.010 OR 0.244). No significant logistic regression correlation was found between other factors and favorable surgical outcomes (p > 0.05). (Table 3).
Table 3
Logistic analysis of predictors of postoperative efficacy (n = 45)
 
Univariate Logistic Analysis
Multivariate Logistic Analysis
 
OR (95%CI)
P
OR (95%CI)
P
Age
1.032 (0.981, 1.085)
0.220
  
Duration of disease
1.008 (0.997, 1.019)
0.165
  
Unilateral/Bilateral lesions
0.582 (0.173, 1.954)
0.381
  
Whether combined with seminal tract stones/cysts
0.250 (0.076, 0.821)
0.022*
0.244 (0.083, 0.716)
0.010*
Whether the seminal vesicle MRI manifested fresh bleeding or non-fresh bleeding
0.281 (0.026, 3.102)
0.300
  
OR Odds ratio, CI Confidence interval, * P < 0.05

Discussion

Advancements in endoscopy and minimally invasive technology have revolutionized the management of diseases that traditionally require open surgery or pose challenges in treatment [6]. While hematospermia may not have serious consequences for men, its recurrent occurrence negatively impacts both male reproductive health and mental well-being and strains relationships between partners. Recently, seminal vesiculoscopy has emerged as a vital technique for addressing hematospermia, ejaculatory duct obstructive azoospermia [7], and other related conditions, gradually gaining popularity. This advancement has significantly benefited affected patients but has also raised the bar for urologists, demanding higher standards of practice. This study explored and compared the effectiveness of various surgical approaches and disease conditions in treating hematospermia using seminal vesiculoscopy.

Current status of hematospermia and operation methods

Hematospermia refers to the presence of blood during ejaculation [8]. While generally benign and self-limiting, it often causes significant anxiety and distress in affected individuals. The condition is commonly associated with inflammation, infection [9, 10], tumors, or systemic diseases [11]. In many hematospermia patients, ejaculatory duct stones have been found to be the root cause of hematospermia [12]. If hemotospermia is accompanied by seminal vesicle or ejaculatory duct stones, preoperative imaging is very crucial. Computerized Tomography (CT) is unsuitable for detecting small and relatively soft seminal vesicle stones, which are often the cause of refractory hematospermia. Contrarily, MRI is a preferred modality for determining the location of blood accumulation within the seminal vesicle and detecting low signal shadows indicative of stones [13]. Transrectal ultrasound screening (TRUS) is also employed for evaluating patients and identifying ejaculatory duct stones in hematospermia patients [1418]. However, MRI examination demonstrates a higher positive rate and better ability to detect stones primarily composed of protein materials, compared to TRUS [1922]. Therefore, our research performed routine seminal vesicle MRI scans and enhanced examinations before surgery. Currently, the treatment options for hematospermia primarily include conservative and surgical approaches. Surgical treatments encompass open and laparoscopic surgery and transurethral seminal vesiculoscopy. Traditional open surgical approaches for treating primary or secondary lesions of the seminal vesicle glands have inherent drawbacks and necessitate significant incisions for access. These open surgeries involve extensive anatomical manipulation, leading to complications associated with exposed surgical fields, prolonged operative times, and intra-abdominal ruptures. To overcome these complications, laparoscopic and endoscopic methods are viable alternatives to conventional surgical interventions [23, 24]. Laparoscopy is the preferred surgical approach for large stones in the seminal vesicles or ejaculatory ducts [24]. Similarly, the seminal vesiculoscopy technique offers distinct advantages in the direct visualization and exploration of the distal end of the seminal tract, enabling accurate diagnosis and treatment of hematospermia. This technique involves the removal of blood clots, stones, and infected seminal vesicle fluid from the seminal vesicle cavity [4, 10]. Hence, seminal vesiculoscopy is highly recommended in the current clinical setting. Liao et al. [25] conducted a meta-analysis involving 584 patients and demonstrated that transurethral seminal vesiculoscopy was more effective than conventional drug therapy in treating hematospermia, with a lower recurrence rate. Compared to seminal vesicle puncture and catheterization, seminal vesiculoscopy shows comparable efficacy but lower rates of postoperative complications and hematospermia recurrence [17, 18, 26]. Wang et al. [27] reported that in 64 cases of seminal vesiculitis treated with seminal vesiculoscopy, complete resolution of hematospermia was observed in 52 cases, partial improvement in eight cases, and no change in four cases three months after the procedure. These findings confirmed the efficacy of seminal vesiculoscopy in treating hematospermic seminal vesiculitis, allowing for seminal vesicle inspection, removal of stones and inflammatory substances, and a lack of significant complications, making it a valuable clinical approach deserving of wider adoption. Our data revealed a total recurrence rate of 32.35% in hematospermia patients after seminal vesicle endoscopy, indicating a favorable efficacy of seminal vesiculoscopy in treating hematospermia. However, it is noteworthy that the operative space within the seminal vesicles is limited, requiring surgeons to be proficient in systematic intracavitary techniques. During the procedure, gentle and delicate movements are crucial to minimize the risk of iatrogenic injuries and postoperative complications.

The birth of the seminal vesiculoscopy technique and its surgical approach

Ozgok et al. [23] first reported successfully removing seminal vesicle stones using transurethral endoscopy in 2005. The procedure involved placing the patient in the lithotomy position and inserting a 6.9F flexible ureteroscope through a guide wire to access the seminal vesicle. The stones were then crushed using forceps. Subsequently, Cuda et al. and Modi [21, 28] announced the clinical application of seminal vesiculoscopy lithotripsy, with both achieving favorable outcomes and contributing to developing the transurethral seminal vesiculoscopy technique. However, there is limited research comparing the efficacy of different surgical approaches for seminal vesiculoscopy. Chen et al. [29] reported that among 419 patients, methods A, D, and C were used in treatings eight (1.9%), 32 (7.6%), and 341 (81.4%) patients, respectively, while 38 cases (9.1%) resulted in failed operations. Liao et al. [5] included 305 patients and implemented methods A–C in seven (2.3%), 229 (75.1%), and 38 (12.5%) patients, respectively. The remaining nine cases (3.0%) resulted in failed operations. Besides, Hu et al. [30] conducted seminal vesiculoscopy in 38 hematospermia patients, with method A accounting for 3.21% and method C accounting for 88.89%. These findings highlighted that a smaller proportion of patients underwent successful seminal vesiculoscopy examination and treatment through natural orifices, with the majority being treated successfully by establishing a side channel at the bottom of the PU. However, a few patients experienced operation failure due to seminal vesicle gland atrophy, deformities, or other reasons [31]. It is worth noting that these cases were performed when the natural orifices of the ejaculatory duct could not be accessed, and there is a lack of comparative data regarding the postoperative effects of different approaches. However, the natural orifices approach remains the preferred method, and efforts should be made to minimize incisions and local invasive procedures. Our conclusion supports the notion that the recurrence rate of patients following the natural orifices approach is the lowest. Now analyzing the reasons behind our findings: (1) when considering the severity of the disease, the methods of fenestration in the PU and transurethral resection to expose the ejaculatory duct orifice are suitable for cases involving ejaculatory duct obstruction or spermary duct disease. These approaches are employed when natural orifices cannot be accessed normally. Pathological changes in the seminal tract at different stages are more pronounced in patients requiring these alternative methods than those who can undergo procedures through natural orifices. It is speculated that through natural orifices without incisions, the involvement of ejaculatory duct orifices in the seminal tract or vesicle pathology is less severe. Consequently, removing factors like seminal tract stones/cysts significantly reduces the recurrence rate of hematospermia. (2) the intraoperative effects on efficacy are noteworthy. Surgical procedures that can be performed through natural orifices without incisions preserve the original anatomical structure to a greater extent, minimizing interference with the entire seminal tract. This approach can attenuate the pressurization effect of seminal tract smooth muscle contraction on the seminal vesicles during ejaculation, counteracting or inhibiting reverse conduction force and preventing reinvasion of the seminal vesicles. Conversely, due to structural changes resulting from transurethral resection (TURED/TUIED) and fenestration in the PU, the fluid mechanics of the seminal tract may be altered, potentially exerting adverse effects on the seminal tract or vesicles. This phenomenon can be likened to the formation of turbulence when blood flows through areas of arterial dissection, which may facilitate thrombus formation. Furthermore, it alters the originally smooth and straight anatomical structure of the ejaculatory duct, making it susceptible to pressure impact at its end corners, thereby altering semen fluid mechanics. Local incisions or the creation of new channels can result in the formation of edema zones, scars, chronic inflammation, and potential narrowing of the seminal tract. These changes increase the risk of bleeding due to the recurrence of related lesions.

Influence of anatomical factors on seminal vesicles endoscopy approach

It is worth noting that our data lacks a comparison involving anatomy-related influencing factors. Domestically and internationally, researchers are still in the exploratory phase of understanding the ejaculatory duct anatomy. The distribution of the ejaculatory duct orifice can directly impact the design of surgical approaches. Li et al. [32] were the first to propose that the ejaculatory duct opening is concealed due to the surface being covered with a one-way valve. This makes locating the ejaculatory duct orifices challenging. Shao et al. [33] conducted a statistical analysis of the ejaculatory duct orifices in 56 patients who underwent seminal vesicle surgery. They sectioned the edge of the PU from the top of the midline of the seminal verumontanum and classified the ejaculatory duct orifice into three types. The success rate of different access channels varies depending on the type.
Through the analysis of predictive factors, it has been determined that the presence of seminal tract stones/cysts is a reliable predictor of non-recurrence after hematospermia surgery using the natural orifices approach. Analyzing the reasons behind this predictive factor: (1) Many cases of seminal vesicle stones are associated with urinary tract infections, abnormalities, obstructions, and ejaculatory reflux [34]. Liu et al. [10] conducted seminal vesiculoscopy on patients with persistent and recurrent hematospermia and discovered that infections might initially stimulate the thickening of the ejaculatory duct membranous wall, resulting in stenosis and further exacerbating the infection due to impaired drainage. In some cases, infection and stenosis can contribute to stone formation. Conversely, stones can cause obstruction and frequent recurrence of infections. Briefly, stenosis, infection, and stones create a vicious cycle that perpetuates the infection, rendering it unresponsive to antibiotic treatment and ultimately leading to persistent or recurrent hematospermia [10]. Removing the stones breaks this vicious cycle, restoring the patency of the seminal tract and resolving the issue. (2) Urine reflux may also be the cause of the formation of stones in the seminal tract. When the discharge of ejaculatory duct secretions blocked, urine reflux, siltation and subsequent debris, coupled with urinary tract infection and seminal vesiculitis, can lead to the occurrence and formation of seminal vesicle stones and ejaculatory duct stones [3, 17, 21, 23, 28, 3538]. The presence of these stones can create a one-way valve effect at the entrance of the seminal vesicles and ejaculatory ducts. By utilizing the natural orifice approach for stone crushing and removal, the obstruction caused by the stones can be relieved and the spermatic tract can be directly cleared. This approach reduces the likelihood of bleeding due to increased pressure in the seminal vesicles or ejaculatory ducts at a later stage.
In some clinical cases, urine reflux has been observed after transurethral ejaculatory duct related operation [21, 39], which could be attributed to accessing the ejaculatory duct through an unnatural orifice. Unlike the presence of sphincter function or peristalsis, the prevention of urine reflux in the ejaculatory duct relies solely on the acute angle formed between the ejaculatory duct and the PU. Animal experiments have demonstrated a similarity in the relationship between the seminal vesicle and the ejaculatory duct and that of the bladder and the urethra. When creating an opening to access the ejaculatory duct, it essentially forms a pseudo channel. If the opening size is too large, reflux may occur, whereas if it is too small, it may cause recurrent stenosis or even occlusion post-surgery [7, 35, 40, 41]. These two outcomes can contribute to the recurrence of hematospermia.
(3) Studies have indicated that stone formation can occur due to cyst blockage or impaired drainage of secretions during ejaculation [35]. The persistence of cysts and stones causes persistent blockage of the drainage. Moreover, patients with seminal vesicle stones often exhibit wall thickening in the seminal vesicle glands and ejaculatory ducts, further obstructing the discharge of secretions [12, 17, 35, 42, 43]. Therefore, the key to alleviating or resolving this issue lies in removing the underlying cause of the stones, which subsequently improves the condition of hypertensive seminal vesicle glands. By addressing these factors, post-operative hematospermia can be prevented.
Besides, we speculated that disturbances in the physiological state of the seminal vesicle glands may cause stone formation, resulting in hematospermia. While the seminal vesicle glands contribute to the production and excretion of semen containing mature sperm in coordination with other reproductive organs [2, 44], it is worth noting that the seminal vesicle itself is not a reservoir for semen. Its primary function lies in the secretion of a liquid comprising proteins, fructose, and various enzymes that nourish sperm [2, 45]. These components indirectly contribute to the stone composition. When the smooth discharge of semen is impeded, the concentration of these substances increases, thereby accelerating stone formation.
This study has several limitations, primarily due to its retrospective nature, which inherently introduces bias. Although we have conducted a comparative analysis of the efficacy of each influencing factor and evaluated the differences in surgical approaches, it is important to acknowledge the need for future investigations with larger case numbers and more comprehensive research and statistical analyses on the technical aspects. These endeavors are expected to yield clearer surgical indications for treating hematospermia using seminal vesiculoscopy, further enhancing surgical efficacy and uncovering additional insights that can guide the widespread application of seminal vesiculoscopy, thereby better-addressing patient concerns.

Conclusion

The Transurethral seminal vesiculoscopy technique demonstrates a low postoperative recurrence rate in treating hematospermia. Among the various approaches, the intraoperative use of natural orifices through the ejaculatory duct exhibits the lowest recurrence rate. Additionally, seminal tract stones/cysts effectively predict favorable postoperative outcomes.

Acknowledgements

We appreciated Mr. Zhen Wang for assistance.

Declarations

Ethics approval was obtained from Ethics Committee of the First Affiliated Hospital of Fujian Medical University (MTCA,ECFAH of FMU [2015] No.084). Written informed consent was obtained from all patients for participating in this study. All methods were carried out in accordance with relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Stefanovic KB, Gregg PC, Soung M. Evaluation and treatment of hematospermia [J]. Am Fam Physician. 2009;80(12):1421–7.PubMed Stefanovic KB, Gregg PC, Soung M. Evaluation and treatment of hematospermia [J]. Am Fam Physician. 2009;80(12):1421–7.PubMed
2.
Zurück zum Zitat Suh Y, Gandhi J, Joshi G, et al. Etiologic classification, evaluation, and management of hematospermia [J]. Transl Androl Urol. 2017;6(5):959–72.PubMedPubMedCentralCrossRef Suh Y, Gandhi J, Joshi G, et al. Etiologic classification, evaluation, and management of hematospermia [J]. Transl Androl Urol. 2017;6(5):959–72.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Liu BJ, Li J, Li PC, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis [J]. J Int Med Res. 2014;42(1):236–42.PubMedCrossRef Liu BJ, Li J, Li PC, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of intractable seminal vesiculitis [J]. J Int Med Res. 2014;42(1):236–42.PubMedCrossRef
4.
Zurück zum Zitat Song T, Zhang X, Zhang L, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of seminal vesicle stones [J]. Chin Med J (Engl). 2012;125(8):1475–8.PubMed Song T, Zhang X, Zhang L, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of seminal vesicle stones [J]. Chin Med J (Engl). 2012;125(8):1475–8.PubMed
5.
Zurück zum Zitat Liao LG, Li YF, Zhang Y, et al. Etiology of 305 cases of refractory hematospermia and therapeutic options by emerging endoscopic technology [J]. Sci Rep. 2019;9(1):5018.PubMedPubMedCentralCrossRef Liao LG, Li YF, Zhang Y, et al. Etiology of 305 cases of refractory hematospermia and therapeutic options by emerging endoscopic technology [J]. Sci Rep. 2019;9(1):5018.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Tsui C, Klein R, Garabrant M. Minimally invasive surgery: national trends in adoption and future directions for hospital strategy [J]. Surg Endosc. 2013;27(7):2253–7.PubMedCrossRef Tsui C, Klein R, Garabrant M. Minimally invasive surgery: national trends in adoption and future directions for hospital strategy [J]. Surg Endosc. 2013;27(7):2253–7.PubMedCrossRef
7.
Zurück zum Zitat Tang SX, Zhou HL, Ding YL. Effectiveness of transurethral seminal vesiculoscopy in the treatment of persistent hematospermia, and oligoasthenozoospermia and azoospermia from ejaculatory duct obstruction] [J. Zhonghua Yi Xue Za Zhi. 2016;96(36):2872–5.PubMed Tang SX, Zhou HL, Ding YL. Effectiveness of transurethral seminal vesiculoscopy in the treatment of persistent hematospermia, and oligoasthenozoospermia and azoospermia from ejaculatory duct obstruction] [J. Zhonghua Yi Xue Za Zhi. 2016;96(36):2872–5.PubMed
8.
Zurück zum Zitat Klevecka V, Jatulis A, Kraniauskas V, et al. Hemospermia] [J. Medicina (Kaunas). 2005;41(4):359–64.PubMed Klevecka V, Jatulis A, Kraniauskas V, et al. Hemospermia] [J. Medicina (Kaunas). 2005;41(4):359–64.PubMed
10.
Zurück zum Zitat Liu ZY, Sun YH, Xu CL, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience [J]. Asian J Androl. 2009;11(5):566–70.PubMedPubMedCentralCrossRef Liu ZY, Sun YH, Xu CL, et al. Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience [J]. Asian J Androl. 2009;11(5):566–70.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Papp GK, Kopa Z, Szabo F, et al. Aetiology of haemospermia [J]. Andrologia. 2003;35(5):317–20.PubMedCrossRef Papp GK, Kopa Z, Szabo F, et al. Aetiology of haemospermia [J]. Andrologia. 2003;35(5):317–20.PubMedCrossRef
12.
Zurück zum Zitat Littrup PJ, Lee F, McLeary RD, et al. Transrectal US of the seminal vesicles and ejaculatory ducts: clinical correlation [J]. Radiology. 1988;168(3):625–8.PubMedCrossRef Littrup PJ, Lee F, McLeary RD, et al. Transrectal US of the seminal vesicles and ejaculatory ducts: clinical correlation [J]. Radiology. 1988;168(3):625–8.PubMedCrossRef
13.
Zurück zum Zitat Song L, Han H, Lei H, et al. Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy [J]. Andrologia. 2020;52(11):e13804.PubMedPubMedCentralCrossRef Song L, Han H, Lei H, et al. Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy [J]. Andrologia. 2020;52(11):e13804.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews [J]. Syst Rev. 2012;1(2). Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews [J]. Syst Rev. 2012;1(2).
15.
Zurück zum Zitat Corriere JN Jr. Painful ejaculation due to seminal vesicle calculi [J]. J Urol. 1997;157(2):626.PubMedCrossRef Corriere JN Jr. Painful ejaculation due to seminal vesicle calculi [J]. J Urol. 1997;157(2):626.PubMedCrossRef
16.
Zurück zum Zitat Kilciler M, Saglam M, Ozgok Y, et al. Giant seminal vesicle stones. Report of two cases. Urol Int. 2002;69(3):250–1.PubMedCrossRef Kilciler M, Saglam M, Ozgok Y, et al. Giant seminal vesicle stones. Report of two cases. Urol Int. 2002;69(3):250–1.PubMedCrossRef
17.
Zurück zum Zitat Razek A, Elhanbly S, Eldeak A. Transrectal ultrasound in patients with hematospermia. J Ultrasound. 2010;13(1):28–33.PubMedCrossRef Razek A, Elhanbly S, Eldeak A. Transrectal ultrasound in patients with hematospermia. J Ultrasound. 2010;13(1):28–33.PubMedCrossRef
18.
Zurück zum Zitat Yagci C, Kupeli S, Tok C, et al. Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin Imaging. 2004;28(4):286–90.PubMedCrossRef Yagci C, Kupeli S, Tok C, et al. Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin Imaging. 2004;28(4):286–90.PubMedCrossRef
19.
Zurück zum Zitat Amano T, Kunimi K, Ohkawa M. Transrectal ultrasonography of the prostate and seminal vesicles with hemospermia. Urol Int. 1994;53(3):139–42.PubMedCrossRef Amano T, Kunimi K, Ohkawa M. Transrectal ultrasonography of the prostate and seminal vesicles with hemospermia. Urol Int. 1994;53(3):139–42.PubMedCrossRef
20.
Zurück zum Zitat Cho IR, Lee MS, Rha KH, et al. Magnetic resonance imaging in hemospermia [J]. J Urol. 1997;157(1):258–62.PubMedCrossRef Cho IR, Lee MS, Rha KH, et al. Magnetic resonance imaging in hemospermia [J]. J Urol. 1997;157(1):258–62.PubMedCrossRef
21.
Zurück zum Zitat Cuda SP, Brand TC, Thibault GP, et al. Case report: Endoscopic laser lithotripsy of seminal-vesicle stones [J]. J Endourol. 2006;20(11):916–8.PubMedCrossRef Cuda SP, Brand TC, Thibault GP, et al. Case report: Endoscopic laser lithotripsy of seminal-vesicle stones [J]. J Endourol. 2006;20(11):916–8.PubMedCrossRef
22.
Zurück zum Zitat Lencioni R, Ortori S, Cioni D, et al. Endorectal coil MR imaging findings in hemospermia [J]. MAGMA. 1999;8(2):91–7.PubMedCrossRef Lencioni R, Ortori S, Cioni D, et al. Endorectal coil MR imaging findings in hemospermia [J]. MAGMA. 1999;8(2):91–7.PubMedCrossRef
23.
Zurück zum Zitat Ozgok Y, Kilciler M, Aydur E, et al. Endoscopic seminal vesicle stone removal [J]. Urology. 2005;65(3):591.PubMedCrossRef Ozgok Y, Kilciler M, Aydur E, et al. Endoscopic seminal vesicle stone removal [J]. Urology. 2005;65(3):591.PubMedCrossRef
24.
Zurück zum Zitat Ping H, Yang YR, Zhang XY, et al. Laparoscopic treatment of a calcium fluorophosphate stone within a seminal vesicle cyst [J]. Asian J Androl. 2010;10(002):337–40. Ping H, Yang YR, Zhang XY, et al. Laparoscopic treatment of a calcium fluorophosphate stone within a seminal vesicle cyst [J]. Asian J Androl. 2010;10(002):337–40.
25.
Zurück zum Zitat Liao J, Ren ZJ, Yang B, et al. Efficacy and security of seminal vesiculoscopy in the treatment of chronic spermatocystitis and hematospermia: a Meta-analysis [J]. Chin J Clin Res. 2018;05:39–44. Liao J, Ren ZJ, Yang B, et al. Efficacy and security of seminal vesiculoscopy in the treatment of chronic spermatocystitis and hematospermia: a Meta-analysis [J]. Chin J Clin Res. 2018;05:39–44.
26.
Zurück zum Zitat Wang R, Chen L, Bai X, et al. Transrectal ultrasound-guided seminal vesicle catheterization with continuous antibiotic infusion for the treatment of refractory hematospermia [J]. Exp Ther Med. 2021;21(1):32.PubMed Wang R, Chen L, Bai X, et al. Transrectal ultrasound-guided seminal vesicle catheterization with continuous antibiotic infusion for the treatment of refractory hematospermia [J]. Exp Ther Med. 2021;21(1):32.PubMed
27.
Zurück zum Zitat Wang R, Zhang WX, Zhang TB, et al. Transurethral seminal vesiculoscopy for the treatment of vesiculitis with hemospermia: A report of 64 cases] [J. Zhonghua Nan Ke Xue. 2016;22(4):335–8.PubMed Wang R, Zhang WX, Zhang TB, et al. Transurethral seminal vesiculoscopy for the treatment of vesiculitis with hemospermia: A report of 64 cases] [J. Zhonghua Nan Ke Xue. 2016;22(4):335–8.PubMed
28.
Zurück zum Zitat Modi PR. Case report: endoscopic management of seminal vesicle stones with cutaneous fistula [J]. J Endourol. 2006;20(6):432–5.PubMedCrossRef Modi PR. Case report: endoscopic management of seminal vesicle stones with cutaneous fistula [J]. J Endourol. 2006;20(6):432–5.PubMedCrossRef
29.
Zurück zum Zitat Chen R, Wang L, Sheng X, et al. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases [J]. Asian J Androl. 2018;20(5):438–41.PubMedPubMedCentralCrossRef Chen R, Wang L, Sheng X, et al. Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases [J]. Asian J Androl. 2018;20(5):438–41.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Hu JC, Chen CS. Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience [J]. Int J Urol. 2018;25(6):589–95.PubMedCrossRef Hu JC, Chen CS. Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience [J]. Int J Urol. 2018;25(6):589–95.PubMedCrossRef
31.
Zurück zum Zitat Chen WK, Yu DD, Wu ZG. Application of transurethral seminal vesiculoscopy in uroandrology] [J. Zhonghua Nan Ke Xue. 2020;26(10):938–43.PubMed Chen WK, Yu DD, Wu ZG. Application of transurethral seminal vesiculoscopy in uroandrology] [J. Zhonghua Nan Ke Xue. 2020;26(10):938–43.PubMed
32.
Zurück zum Zitat Li ZY, Xu Y, Liu C, et al. Anatomical study of the seminal vesicle system for transurethral seminal vesiculoscopy [J]. Clin Anat. 2019;32(2):244–52.PubMedCrossRef Li ZY, Xu Y, Liu C, et al. Anatomical study of the seminal vesicle system for transurethral seminal vesiculoscopy [J]. Clin Anat. 2019;32(2):244–52.PubMedCrossRef
33.
Zurück zum Zitat Shao JC, Zeng ZJ, Wang X, et al. Distribution of ejaculatory duct openings and the method of entering the vesiculoscope into the seminal vesicle] [J. Zhonghua Nan Ke Xue. 2018;24(8):686–9.PubMed Shao JC, Zeng ZJ, Wang X, et al. Distribution of ejaculatory duct openings and the method of entering the vesiculoscope into the seminal vesicle] [J. Zhonghua Nan Ke Xue. 2018;24(8):686–9.PubMed
34.
Zurück zum Zitat Yun SJ, Kim TH, Kwon WA, et al. A Large Stone in the Dilated Left Seminal Vesicle: Laparoscopic Removal and Partial Seminal Vesiculectomy [J]. Korean J Urol. 2008,49(7):656–8. Yun SJ, Kim TH, Kwon WA, et al. A Large Stone in the Dilated Left Seminal Vesicle: Laparoscopic Removal and Partial Seminal Vesiculectomy [J]. Korean J Urol. 2008,49(7):656–8.
35.
Zurück zum Zitat Christodoulidou M, Parnham A, Nigam R. Diagnosis and management of symptomatic seminal vesicle calculi [J]. Scand J Urol. 2017;51(4):237–44.PubMedCrossRef Christodoulidou M, Parnham A, Nigam R. Diagnosis and management of symptomatic seminal vesicle calculi [J]. Scand J Urol. 2017;51(4):237–44.PubMedCrossRef
36.
Zurück zum Zitat Li YK. Diagnosis and management of large seminal vesicle stones [J]. Br J Urol. 1991;68(3):322–3.PubMedCrossRef Li YK. Diagnosis and management of large seminal vesicle stones [J]. Br J Urol. 1991;68(3):322–3.PubMedCrossRef
37.
Zurück zum Zitat Wesson L, Steinhardt G. Case profile: seminal vesicle stones [J]. Urology. 1983;22(2):204–5.PubMedCrossRef Wesson L, Steinhardt G. Case profile: seminal vesicle stones [J]. Urology. 1983;22(2):204–5.PubMedCrossRef
38.
Zurück zum Zitat Wilkinson AG. Case report: calculus in the seminal vesicle [J]. Pediatr Radiol. 1993;23(4):327.PubMedCrossRef Wilkinson AG. Case report: calculus in the seminal vesicle [J]. Pediatr Radiol. 1993;23(4):327.PubMedCrossRef
39.
Zurück zum Zitat Vellayappan BA, Tiong HY, Chua WJ, et al. Seminal vesicle calculus after transurethral resection of ejaculatory duct [J]. Can J Urol. 2007;14(3):3595–7.PubMed Vellayappan BA, Tiong HY, Chua WJ, et al. Seminal vesicle calculus after transurethral resection of ejaculatory duct [J]. Can J Urol. 2007;14(3):3595–7.PubMed
40.
Zurück zum Zitat Pang K, Dong BZ, Han CH. Commentary on “Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases” [J]. Asian J Androl. 2020;22(2):227–8.PubMedCrossRef Pang K, Dong BZ, Han CH. Commentary on “Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases” [J]. Asian J Androl. 2020;22(2):227–8.PubMedCrossRef
41.
Zurück zum Zitat Turek PJ, Aslam K, Younes AK, et al. Observations on seminal vesicle dynamics in an in vivo rat model [J]. J Urol. 1998;159(5):1731–4.PubMedCrossRef Turek PJ, Aslam K, Younes AK, et al. Observations on seminal vesicle dynamics in an in vivo rat model [J]. J Urol. 1998;159(5):1731–4.PubMedCrossRef
42.
Zurück zum Zitat Corriere JN, Jr. Painful ejaculation due to seminal vesicle calculi [J]. J Urol. 1997;157(2):626.PubMedCrossRef Corriere JN, Jr. Painful ejaculation due to seminal vesicle calculi [J]. J Urol. 1997;157(2):626.PubMedCrossRef
43.
Zurück zum Zitat Drach GW. Campbell's Urology [M]. Philadelphia: Elsevier; 1992. Drach GW. Campbell's Urology [M]. Philadelphia: Elsevier; 1992.
44.
Zurück zum Zitat Dagur G, Warren K, Suh Y, et al. Detecting diseases of neglected seminal vesicles using imaging modalities: A review of current literature [J]. International Journal of Reproductive Biomedicine. 2016;14(5):293–302.PubMedPubMedCentral Dagur G, Warren K, Suh Y, et al. Detecting diseases of neglected seminal vesicles using imaging modalities: A review of current literature [J]. International Journal of Reproductive Biomedicine. 2016;14(5):293–302.PubMedPubMedCentral
45.
Metadaten
Titel
Efficacy of various surgical approaches in treating hematospermia using transurethral seminal vesiculoscopy
verfasst von
Rui-Jie Yao
Hong Xiao
Shu-Shen Chen
Zhi-Hao Feng
Yi-Lang Ding
Xi Chen
Song-Xi Tang
Hui-Liang Zhou
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Surgery / Ausgabe 1/2023
Elektronische ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-023-02290-2

Weitere Artikel der Ausgabe 1/2023

BMC Surgery 1/2023 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.